White House readies nicotine proposal in administration’s final days
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story FDA rule to lower nicotine levels closes ...
STAT16h
Leaving FDA, Califf is unapologetic — and warns of staff departures
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...
STAT7d
Save the Food and Drug Administration by breaking it up
Snake oil, it turns out, motivated the founding of the FDA. The term “snake oil” arose out of a controversy from the late ...
JD Supra20h
Balancing Safety and Accessibility: FDA Broadens Approval Pathway for Nonprescription Drugs by Finalizing the ‘ACNU’ Rule
The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...
The FDA Set Guidelines for 'Acceptable' Levels of Lead in Baby Food for the First Time — but Some Experts Say It's Not Enough
On Monday, the U.S. Food and Drug Administration (FDA) announced that, for the first time, it is setting guidelines for an ...
FDA's Food Safety Inspections Struggle Amid Staffing Shortfall
The FDA has failed to meet its mandated targets for domestic and foreign food safety inspections since fiscal 2018, the US ...
JD Supra1d
MoCRA Guidance Update for Registration and Listing of Cosmetic Product Facilities and Products
What Happened: The Food and Drug Administration (FDA) released new guidance regarding the registration and listing of ...
Quality Assurance2d
FDA Releases Allergen, Food Safety and Plant-Based Alternative Labeling Guidance
The four new guidance documents are designed to help industry and other interest holders understand and comply with FDA ...
UPI13d
FDA proposes rule to target asbestos in talc cosmetic products
The U.S. Food and Drug Administration (FDA ... Drug, and Cosmetic Act. Asbestos contamination in talc-based cosmetics has been a long-standing health concern. The FDA emphasized there is no ...
Cure Today4d
FDA Accepts New Drug Application For Taletrectinib in ROS1+ NSCLC
The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell ...